These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30338939)

  • 1. Prostaglandin E2 increases migration and proliferation of human glioblastoma cells by activating transient receptor potential melastatin 7 channels.
    Tian Y; Yang T; Yu S; Liu C; He M; Hu C
    J Cell Mol Med; 2018 Dec; 22(12):6327-6337. PubMed ID: 30338939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.
    Chen WL; Barszczyk A; Turlova E; Deurloo M; Liu B; Yang BB; Rutka JT; Feng ZP; Sun HS
    Oncotarget; 2015 Jun; 6(18):16321-40. PubMed ID: 25965832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells.
    Leng TD; Li MH; Shen JF; Liu ML; Li XB; Sun HW; Branigan D; Zeng Z; Si HF; Li J; Chen J; Xiong ZG
    CNS Neurosci Ther; 2015 Mar; 21(3):252-61. PubMed ID: 25438992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing TRPM7 in mouse cortical astrocytes impairs cell proliferation and migration via ERK and JNK signaling pathways.
    Zeng Z; Leng T; Feng X; Sun H; Inoue K; Zhu L; Xiong ZG
    PLoS One; 2015; 10(3):e0119912. PubMed ID: 25799367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1.
    Peng Y; Shi J; Du X; Wang L; Klocker H; Mo L; Mo Z; Zhang J
    Int J Biochem Cell Biol; 2013 Mar; 45(3):521-30. PubMed ID: 23246486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the novel Mg2+ transporter transient receptor potential melastatin 7 (TRPM7) cation channel by bradykinin in vascular smooth muscle cells.
    Callera GE; He Y; Yogi A; Montezano AC; Paravicini T; Yao G; Touyz RM
    J Hypertens; 2009 Jan; 27(1):155-66. PubMed ID: 19145781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
    Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
    Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
    Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
    Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing TRPM7 promotes growth/proliferation and nitric oxide production of vascular endothelial cells via the ERK pathway.
    Inoue K; Xiong ZG
    Cardiovasc Res; 2009 Aug; 83(3):547-57. PubMed ID: 19454490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation.
    Jiang J; Li MH; Inoue K; Chu XP; Seeds J; Xiong ZG
    Cancer Res; 2007 Nov; 67(22):10929-38. PubMed ID: 18006838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 promotes human cholangiocarcinoma cell proliferation, migration and invasion through the upregulation of β-catenin expression via EP3-4 receptor.
    Du M; Shi F; Zhang H; Xia S; Zhang M; Ma J; Bai X; Zhang L; Wang Y; Cheng S; Yang Q; Leng J
    Oncol Rep; 2015 Aug; 34(2):715-26. PubMed ID: 26058972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR).
    Ye Y; Peng L; Vattai A; Deuster E; Kuhn C; Dannecker C; Mahner S; Jeschke U; von Schönfeldt V; Heidegger HH
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2189-2203. PubMed ID: 32488496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient Receptor Potential Melastatin 7 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma.
    Nakashima S; Shiozaki A; Ichikawa D; Hikami S; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Otsuji E
    Anticancer Res; 2017 Mar; 37(3):1161-1167. PubMed ID: 28314277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
    Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
    Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPM7 is Involved in the Regulation of Proliferation, Migration and Osteogenic Differentiation of Human Dental Follicle Cells.
    Zuo D; Li J; Huang Y; Li J; Yao S; Xiong L; Zeng J
    Front Biosci (Landmark Ed); 2023 May; 28(5):104. PubMed ID: 37258464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EP1/EP3 receptor agonist 17-pt-PGE
    Theiler A; Konya V; Pasterk L; Maric J; Bärnthaler T; Lanz I; Platzer W; Schuligoi R; Heinemann A
    Vascul Pharmacol; 2016 Dec; 87():180-189. PubMed ID: 27664754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways.
    Woo SM; Min KJ; Chae IG; Chun KS; Kwon TK
    Mol Carcinog; 2015 Mar; 54(3):216-28. PubMed ID: 24127286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1
    Yang F; Cai J; Zhan H; Situ J; Li W; Mao Y; Luo Y
    Oxid Med Cell Longev; 2020; 2020():6724810. PubMed ID: 32215176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
    Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
    Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells.
    Bazzani L; Donnini S; Finetti F; Christofori G; Ziche M
    Oncotarget; 2017 May; 8(19):31270-31287. PubMed ID: 28415726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.